Royal Bank of Canada’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$799K Buy
22,619
+3,790
+20% +$154K ﹤0.01% 3796
2025
Q4
$764K Sell
18,829
-212,531
-92% -$9.25M ﹤0.01% 3853
2025
Q3
$10.9M Buy
231,360
+51,374
+29% +$2.66M ﹤0.01% 2090
2025
Q2
$9.37M Buy
179,986
+147,733
+458% +$8.11M ﹤0.01% 2082
2025
Q1
$1.95M Sell
32,253
-168,425
-84% -$10.9M ﹤0.01% 2965
2024
Q4
$13.7M Sell
200,678
-29,162
-13% -$2.03M ﹤0.01% 1595
2024
Q3
$16.5M Buy
229,840
+9,544
+4% +$673K ﹤0.01% 1467
2024
Q2
$15.3M Sell
220,296
-3,443
-2% -$251K ﹤0.01% 1401
2024
Q1
$17.9M Sell
223,739
-22,574
-9% -$2.01M ﹤0.01% 1322
2023
Q4
$27M Buy
246,313
+41,780
+20% +$4.32M 0.01% 1106
2023
Q3
$20.6M Buy
204,533
+185,520
+976% +$21.3M 0.01% 1142
2023
Q2
$2.58M Sell
19,013
-99
-0.5% -$12.1K ﹤0.01% 2632
2023
Q1
$1.99M Sell
19,112
-3,109
-14% -$301K ﹤0.01% 2803
2022
Q4
$1.97M Buy
22,221
+3,650
+20% +$303K ﹤0.01% 2912
2022
Q3
$1.49M Buy
18,571
+2,110
+13% +$199K ﹤0.01% 3096
2022
Q2
$1.58M Sell
16,461
-272
-2% -$32.6K ﹤0.01% 3101
2022
Q1
$2.49M Sell
16,733
-3,388
-17% -$473K ﹤0.01% 2860
2021
Q4
$2.85M Buy
20,121
+5,793
+40% +$820K ﹤0.01% 2852
2021
Q3
$1.87M Buy
14,328
+2,309
+19% +$302K ﹤0.01% 3122
2021
Q2
$1.65M Buy
12,019
+3,789
+46% +$519K ﹤0.01% 3224
2021
Q1
$1.08M Sell
8,230
-10,696
-57% -$1.29M ﹤0.01% 3511
2020
Q4
$2.12M Sell
18,926
-945
-5% -$89.5K ﹤0.01% 2865
2020
Q3
$1.56M Buy
19,871
+1,033
+5% +$84.2K ﹤0.01% 2900
2020
Q2
$1.36M Buy
18,838
+3,984
+27% +$277K ﹤0.01% 2921
2020
Q1
$851K Buy
14,854
+7,729
+108% +$713K ﹤0.01% 3164
2019
Q4
$796K Sell
7,125
-9,696
-58% -$1.03M ﹤0.01% 3629
2019
Q3
$1.62M Buy
16,821
+304
+2% +$28.5K ﹤0.01% 2932
2019
Q2
$1.41M Buy
16,517
+2,467
+18% +$203K ﹤0.01% 3029
2019
Q1
$1.17M Buy
14,050
+1,122
+9% +$81.5K ﹤0.01% 3090
2018
Q4
$830K Sell
12,928
-1,732
-12% -$119K ﹤0.01% 3315
2018
Q3
$1.16M Sell
14,660
-261
-2% -$20.2K ﹤0.01% 3245
2018
Q2
$1.09M Sell
14,921
-265
-2% -$18K ﹤0.01% 3159
2018
Q1
$962K Sell
15,186
-700
-4% -$41.8K ﹤0.01% 3196
2017
Q4
$809K Sell
15,886
-3,623
-19% -$189K ﹤0.01% 3395
2017
Q3
$1.02M Buy
19,509
+2,278
+13% +$114K ﹤0.01% 3202
2017
Q2
$877K Sell
17,231
-522
-3% -$25.8K ﹤0.01% 3206
2017
Q1
$788K Sell
17,753
-6,911
-28% -$297K ﹤0.01% 3261
2016
Q4
$1.09M Buy
24,664
+5,807
+31% +$247K ﹤0.01% 3077
2016
Q3
$755K Buy
18,857
+57
+0.3% +$2.42K ﹤0.01% 3355
2016
Q2
$897K Hold
18,800
﹤0.01% 3211
2016
Q1
$788K Sell
18,800
-98
-0.5% -$3.85K ﹤0.01% 3257
2015
Q4
$832K Sell
18,898
-16,132
-46% -$700K ﹤0.01% 3282
2015
Q3
$1.67M Buy
35,030
+14,741
+73% +$809K ﹤0.01% 2418
2015
Q2
$1.18M Buy
20,289
+1,489
+8% +$80.3K ﹤0.01% 2745
2015
Q1
$949K Sell
18,800
-1,439
-7% -$70.5K ﹤0.01% 2931
2014
Q4
$910K Buy
20,239
+1,439
+8% +$60.3K ﹤0.01% 3005
2014
Q3
$693K Sell
18,800
-11,613
-38% -$461K ﹤0.01% 3153
2014
Q2
$1.34M Sell
30,413
-133
-0.4% -$6.03K ﹤0.01% 2589
2014
Q1
$1.33M Buy
30,546
+11,746
+62% +$523K ﹤0.01% 2543
2013
Q4
$799K Sell
18,800
-3,200
-15% -$122K ﹤0.01% 3021
2013
Q3
$747K Sell
22,000
-22,397
-50% -$731K ﹤0.01% 3035
2013
Q2
$1.39M Buy
+44,397
New +$1.44M ﹤0.01% 2324

Other funds holding CNMD

Royal Bank of Canada's CNMD Position: Q1 2026 in Review

Royal Bank of Canada increased its CONMED (CNMD) stake by 20% in Q1 2026, buying an estimated $154K and bringing the position to 22,619 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #3796.

Royal Bank of Canada first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q4 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Royal Bank of Canada held 22,619 shares of CONMED worth $799K as of Q1 2026.
  • Royal Bank of Canada bought 3,790 CONMED shares in Q1 2026, an estimated $154K.
  • CONMED made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3796 holding.
  • Royal Bank of Canada first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's CONMED position peaked at $27M in Q4 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.